The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets (Q28572048)

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets (English)

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Barbara E. Corkey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Lisa Getty-Kaushik

1

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sarah Krawczyk

4

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Orian Shirihai

5

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ann-Marie T Richard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

30 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

17

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

10

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

1856-1860

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

4 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Leptin-regulated endocannabinoids are involved in maintaining food intake

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

The endocannabinoid system in obesity and type 2 diabetes.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Endocannabinoids: some like it fat (and sweet too).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Rimonabant: new data and emerging experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Food for thought: endocannabinoid modulation of lipogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Endocannabinoid control of food intake and energy balance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Fatty acids, lipotoxicity and insulin secretion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Oscillations in cytosolic free Ca2+, oxygen consumption, and insulin secretion in glucose-stimulated rat pancreatic islets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

3 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Presence of functional cannabinoid receptors in human endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3808997

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

27 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: Insulin and melanocortins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

31 March 2020

Intra-islet regulation

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Alpha- and beta-cell function in obese Zucker (fa/fa) rats: a study with the isolated perfused pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

Low-carbohydrate diets affect energy balance and fuel homeostasis differentially in lean and obese rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.234

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.234

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19644453%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2 references